AAP
COLL icon

Arax Advisory Partners’s Collegium Pharmaceutical COLL Stock Holding History

Arax Advisory Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4K Sell
646
-959
-60% -$32.8K ﹤0.01% 3853
2026
Q1 		$57.1K Buy
1,605
+1,359
+552% +$57.5K ﹤0.01% 1633
2025
Q4 		$11.4K Buy
246
+4
+2% +$167 ﹤0.01% 2400
2025
Q3 		$8.47K Sell
242
-1,754
-88% -$61K ﹤0.01% 2672
2025
Q2 		$59K Buy
+1,996
New +$56.9K ﹤0.01% 1156
2025
Q1 		– Sell
-108
Closed -$3.1K – 2740
2024
Q4 		$3.1K Sell
108
-47
-30% -$1.55K ﹤0.01% 1898
2024
Q3 		$5.99K Hold
155
– – ﹤0.01% 1640
2024
Q2 		$4.99K Buy
+155
New +$5.37K ﹤0.01% 1595

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Arax Advisory Partners's COLL Position: Q2 2026 in Review

Arax Advisory Partners reduced its Collegium Pharmaceutical (COLL) stake by 60% in Q2 2026, selling an estimated $32.8K and leaving 646 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3853.

Arax Advisory Partners first reported a position in COLL in Q2 2024 and has held it in 8 quarters since. The position peaked at $59K in Q2 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Arax Advisory Partners held 646 shares of Collegium Pharmaceutical worth $23.4K as of Q2 2026.
  • Arax Advisory Partners sold 959 Collegium Pharmaceutical shares in Q2 2026, an estimated $32.8K.
  • Collegium Pharmaceutical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3853 holding.
  • Arax Advisory Partners first reported a position in Collegium Pharmaceutical in Q2 2024 and has held it in 8 quarters since.
  • Arax Advisory Partners's Collegium Pharmaceutical position peaked at $59K in Q2 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.